MARCU MACAGBA: Open Payments
NPI 1164936001 · DAVENPORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 10 payments from 7 companies in 2025. Trend: 2023 $213 · 2024 $300 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| PFIZER INC. | 2 | $34 |
| Boston Scientific Corporation | 1 | $32 |
| ABBVIE INC. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Korlym, Wegovy, WATCHMAN FLX, QULIPTA, FREESTYLE LIBRE 3, PAXLOVID, FARXIGA, ELIQUIS.
Industry payments across FL — which companies pay providers there.
